Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
Department of Hygiene, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Front Immunol. 2022 Jan 27;13:807696. doi: 10.3389/fimmu.2022.807696. eCollection 2022.
CD8 T cells are the key effector cells that contribute to the antitumor immune response. They comprise various T-cell clones with diverse antigen-specific T-cell receptors (TCRs). Thus, elucidating the overall antitumor responses of diverse T-cell clones is an emerging challenge in tumor immunology. With the recent advancement in next-generation DNA sequencers, comprehensive analysis of the collection of TCR genes (TCR repertoire analysis) is feasible and has been used to investigate the clonal responses of antitumor T cells. However, the immunopathological significance of TCR repertoire indices is still undefined. In this review, we introduce two approaches that facilitate an immunological interpretation of the TCR repertoire data: inter-organ clone tracking analysis and single-cell TCR sequencing. These approaches for TCR repertoire analysis will provide a more accurate understanding of the response of tumor-specific T cells in the tumor microenvironment.
CD8 T 细胞是抗肿瘤免疫反应的关键效应细胞。它们由具有不同抗原特异性 T 细胞受体 (TCR) 的各种 T 细胞克隆组成。因此,阐明不同 T 细胞克隆的总体抗肿瘤反应是肿瘤免疫学中的一个新挑战。随着新一代 DNA 测序仪的出现,全面分析 TCR 基因的集合(TCR 库分析)是可行的,并已用于研究抗肿瘤 T 细胞的克隆反应。然而,TCR 库指数的免疫病理学意义仍未确定。在这篇综述中,我们介绍了两种有助于对 TCR 库数据进行免疫学解释的方法:器官间克隆跟踪分析和单细胞 TCR 测序。这些 TCR 库分析方法将为更准确地了解肿瘤微环境中肿瘤特异性 T 细胞的反应提供依据。